Terns Pharmaceuticals, Inc.
TERN
$25.79
-$1.74-6.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 10.94% | -19.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.22% | -0.16% | |||
| Operating Income | -1.22% | 0.16% | |||
| Income Before Tax | -2.33% | -0.88% | |||
| Income Tax Expenses | -28.13% | -27.27% | |||
| Earnings from Continuing Operations | -2.25% | -0.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.25% | -0.77% | |||
| EBIT | -1.22% | 0.16% | |||
| EBITDA | -1.21% | 0.00% | |||
| EPS Basic | -2.09% | -0.65% | |||
| Normalized Basic EPS | -2.20% | -0.74% | |||
| EPS Diluted | -2.09% | -0.65% | |||
| Normalized Diluted EPS | -2.20% | -0.74% | |||
| Average Basic Shares Outstanding | 0.14% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.14% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||